HB3454 - 104th General Assembly (2025-2026)

EPINEPHRINE DELIVERY DEVICE
Last Action
5/31/2026 - House: Passed Both Houses
Statutes Amended In Order of Appearance
20 ILCS 2610/40  
50 ILCS 705/10.19  
105 ILCS 5/22-30  
215 ILCS 5/356z.33  
225 ILCS 60/65  
410 ILCS 27/1  
410 ILCS 27/5  
410 ILCS 27/10  
410 ILCS 27/15  
410 ILCS 27/20  
410 ILCS 607/10  
410 ILCS 620/3.21  from Ch. 56 1/2, par. 503.21
410 ILCS 642/20  
Synopsis As Introduced
Amends various Acts to change references from "epinephrine auto-injector" or "epinephrine injector" to "FDA approved epinephrine delivery device or product". Changes the name of the Epinephrine Injector Act to the FDA Approved Epinephrine Delivery Device or Product Act.

Senate Floor Amendment No. 2
Deletes reference to:
410 ILCS 642/20  
Replaces everything after the enacting clause with the provisions of the engrossed bill with the following changes. Replaces references in the engrossed bill to "FDA approved epinephrine delivery device or product" with references to "epinephrine delivery system". Makes conforming, technical, and other changes.
Actions
DateChamberAction
2/07/2025HouseFiled with the Clerk by Rep. Joyce Mason
2/18/2025HouseFirst Reading
2/18/2025HouseReferred to Rules Committee
3/11/2025HouseAssigned to Prescription Drug Affordability & Accessibility Committee
3/19/2025HouseDo Pass / Short Debate Prescription Drug Affordability & Accessibility Committee; 013-000-000
3/20/2025HousePlaced on Calendar 2nd Reading - Short Debate
3/26/2025HouseAdded Co-Sponsor Rep. Jawaharial Williams
3/26/2025HouseAdded Co-Sponsor Rep. Harry Benton
3/26/2025HouseAdded Co-Sponsor Rep. Dagmara Avelar
3/26/2025HouseSecond Reading - Short Debate
3/26/2025HouseHeld on Calendar Order of Second Reading - Short Debate
4/08/2025HouseAdded Co-Sponsor Rep. Camille Y. Lilly
4/11/2025HouseRule 19(a) / Re-referred to Rules Committee
1/21/2026HouseAdded Chief Co-Sponsor Rep. Martha Deuter
2/11/2026HouseApproved for Consideration Rules Committee; 005-000-000
2/13/2026HousePlaced on Calendar 2nd Reading - Short Debate
2/25/2026HousePlaced on Calendar Order of 3rd Reading - Short Debate
2/25/2026HouseThird Reading - Short Debate - Passed 105-000-000
2/26/2026SenateArrive in Senate
2/26/2026SenatePlaced on Calendar Order of First Reading March 3, 2026
3/02/2026HouseAdded Co-Sponsor Rep. Michelle Mussman
3/09/2026HouseAdded Chief Co-Sponsor Rep. Janet Yang Rohr
3/26/2026SenateChief Senate Sponsor Sen. Suzy Glowiak Hilton
3/26/2026SenateFirst Reading
3/26/2026SenateReferred to Assignments
4/28/2026SenateAssigned to Insurance
5/06/2026SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Suzy Glowiak Hilton
5/06/2026SenateSenate Committee Amendment No. 1 Referred to Assignments
5/06/2026SenateDo Pass Insurance; 009-000-000
5/06/2026SenatePlaced on Calendar Order of 2nd Reading May 7, 2026
5/14/2026SenateSecond Reading
5/14/2026SenatePlaced on Calendar Order of 3rd Reading May 18, 2026
5/18/2026SenateSenate Floor Amendment No. 2 Filed with Secretary by Sen. Suzy Glowiak Hilton
5/18/2026SenateSenate Floor Amendment No. 2 Referred to Assignments
5/19/2026SenateSenate Floor Amendment No. 2 Be Approved for Consideration Assignments
5/22/2026SenateRule 2-10 Third Reading Deadline Established As May 31, 2026
5/28/2026SenateRecalled to Second Reading
5/28/2026SenateSenate Floor Amendment No. 2 Adopted; Glowiak-Hilton
5/28/2026SenatePlaced on Calendar Order of 3rd Reading
5/28/2026SenateThird Reading - Passed; 059-000-000
5/28/2026SenateAdded as Alternate Co-Sponsor Sen. Mary Edly-Allen
5/28/2026HouseArrived in House
5/28/2026HousePlaced on Calendar Order of Concurrence Senate Amendment(s) 2
5/29/2026HouseSenate Floor Amendment No. 2 Motion Filed Concur Rep. Joyce Mason
5/29/2026HouseSenate Floor Amendment No. 2 Motion to Concur Referred to Rules Committee
5/29/2026HouseAdded Chief Co-Sponsor Rep. Natalie A. Manley
5/29/2026HouseSenate Floor Amendment No. 2 Motion to Concur Rules Referred to Prescription Drug Affordability & Accessibility Committee
5/29/2026HouseSenate Floor Amendment No. 2 Motion to Concur Recommends Be Adopted Prescription Drug Affordability & Accessibility Committee; 013-000-000
5/31/2026HouseSenate Floor Amendment No. 2 House Concurs 116-000-000
5/31/2026HouseHouse Concurs
5/31/2026HousePassed Both Houses